Location: Echo Starhotel Milano, Viale Andrea Doria, 4, 20124 Milan, Italy Join the worldwide Phoenix user community and the Certara Phoenix team to learn about how Phoenix is leveraged to accelerate drug development. The meeting will include presentations from Phoenix users, and updates on the Phoenix vision and roadmap. In addition, Phoenix User Group Meeting … Continued
Therapeutic proteins (TP) – and more specifically monoclonal antibodies – are part of the therapeutic arsenal for the treatment of several diseases, providing effective and safe therapeutic solutions for patients. As part of the usual therapeutic practice, patients often receive drug combinations (TP/TP or TP/small molecules) and/or concomitant co-medications. Thus, drug-drug-interactions (DDIs) can be a … Continued
Drug developers often rush through the discovery process to get into human testing. Most are so curious about their new target or molecule that they may forget that the pharmaceutical formulation process that can easily make or break their program. Once in human testing, revisiting these formulations is often time-consuming. By then, depending on drug … Continued
